These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33073868)

  • 1. Characterization of Placental Microvascular Architecture by MV-Flow Imaging in Normal and Fetal Growth-Restricted Pregnancies.
    Chen X; Wei X; Zhao S; Huang H; Wang W; Qiu J; Chen X; Cheng C; Tian Z; Rychik J
    J Ultrasound Med; 2021 Aug; 40(8):1533-1542. PubMed ID: 33073868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental vascular sonobiopsy using three-dimensional power Doppler ultrasound in normal and growth restricted fetuses.
    Noguchi J; Hata K; Tanaka H; Hata T
    Placenta; 2009 May; 30(5):391-7. PubMed ID: 19327824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of three-dimensional power Doppler combined with two-dimensional Doppler ultrasonography for evaluating fetal growth restriction.
    Fan H; Li L; Hao C
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2322610. PubMed ID: 38418205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study.
    MacDonald TM; Hui L; Robinson AJ; Dane KM; Middleton AL; Tong S; Walker SP
    Ultrasound Obstet Gynecol; 2019 Sep; 54(3):367-375. PubMed ID: 30338593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemodynamics of late-onset intrauterine growth restriction by MRI.
    Zhu MY; Milligan N; Keating S; Windrim R; Keunen J; Thakur V; Ohman A; Portnoy S; Sled JG; Kelly E; Yoo SJ; Gross-Wortmann L; Jaeggi E; Macgowan CK; Kingdom JC; Seed M
    Am J Obstet Gynecol; 2016 Mar; 214(3):367.e1-367.e17. PubMed ID: 26475425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-Dimensional Power Doppler Evaluation of Cerebral Vascular Blood Flow: A Novel Tool in the Assessment of Fetal Growth Restriction.
    Goetzinger KR; Cahill AG; Odibo L; Macones GA; Odibo AO
    J Ultrasound Med; 2018 Jan; 37(1):139-147. PubMed ID: 28708246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added value of cerebro-placental ratio and uterine artery Doppler at routine third trimester screening as a predictor of SGA and FGR in non-selected pregnancies.
    Rial-Crestelo M; Martinez-Portilla RJ; Cancemi A; Caradeux J; Fernandez L; Peguero A; Gratacos E; Figueras F
    J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2554-2560. PubMed ID: 29447050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is three-dimensional power Doppler ultrasound useful in the assessment of placental perfusion in normal and growth-restricted pregnancies?
    Guiot C; Gaglioti P; Oberto M; Piccoli E; Rosato R; Todros T
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):171-6. PubMed ID: 18254148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester placental volume and vascularization measured by 3-dimensional power Doppler sonography in pregnancies with low serum pregnancy-associated plasma protein a levels.
    Rizzo G; Capponi A; Pietrolucci ME; Capece A; Arduini D
    J Ultrasound Med; 2009 Dec; 28(12):1615-22. PubMed ID: 19933473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of placental three-dimensional power Doppler indices and volume in the first and the second trimesters of pregnancy complicated by gestational diabetes mellitus.
    Wong CH; Chen CP; Sun FJ; Chen CY
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3784-3791. PubMed ID: 29716432
    [No Abstract]   [Full Text] [Related]  

  • 12. Two-dimensional and three-dimensional Doppler assessment of fetal growth restriction with different severity and onset.
    Luria O; Barnea O; Shalev J; Barkat J; Kovo M; Golan A; Bar J
    Prenat Diagn; 2012 Dec; 32(12):1174-80. PubMed ID: 23074059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An abnormal cerebroplacental ratio (CPR) is predictive of early childhood delayed neurodevelopment in the setting of fetal growth restriction.
    Monteith C; Flood K; Pinnamaneni R; Levine TA; Alderdice FA; Unterscheider J; McAuliffe FM; Dicker P; Tully EC; Malone FD; Foran A
    Am J Obstet Gynecol; 2019 Sep; 221(3):273.e1-273.e9. PubMed ID: 31226291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Akolekar R; Ciobanu A; Zingler E; Syngelaki A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jul; 221(1):65.e1-65.e18. PubMed ID: 30878322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester measurements of the three-dimensional ultrasound placental volume and uterine artery Doppler in early- and late-onset fetal growth restriction.
    Arakaki T; Hasegawa J; Nakamura M; Takita H; Hamada S; Oba T; Matsuoka R; Sekizawa A
    J Matern Fetal Neonatal Med; 2020 Feb; 33(4):564-569. PubMed ID: 29973102
    [No Abstract]   [Full Text] [Related]  

  • 16. Placental pulsatility index: a new, more sensitive parameter for predicting adverse outcome in pregnancies suspected of fetal growth restriction.
    Gudmundsson S; Flo K; Ghosh G; Wilsgaard T; Acharya G
    Acta Obstet Gynecol Scand; 2017 Feb; 96(2):216-222. PubMed ID: 27858967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental glucose transporter 1 and 3 gene expression in Monochorionic twin pregnancies with selective fetal growth restriction.
    Chang YL; Chao AS; Chang SD; Cheng PJ
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):260. PubMed ID: 33773574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental magnetic resonance imaging T2* measurements in normal pregnancies and in those complicated by fetal growth restriction.
    Sinding M; Peters DA; Frøkjaer JB; Christiansen OB; Petersen A; Uldbjerg N; Sørensen A
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):748-54. PubMed ID: 26041014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-placental arterial Doppler: A marker of fetoplacental vascularity in late-onset placental disease?
    Higgins LE; Heazell AEP; Simcox LE; Johnstone ED
    Acta Obstet Gynecol Scand; 2020 Jul; 99(7):865-874. PubMed ID: 31943128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of normalization of cerebro-placental ratio as a potential predictor for adverse outcome in SGA fetuses.
    Monteith C; Flood K; Mullers S; Unterscheider J; Breathnach F; Daly S; Geary MP; Kennelly MM; McAuliffe FM; O'Donoghue K; Hunter A; Morrison JJ; Burke G; Dicker P; Tully EC; Malone FD
    Am J Obstet Gynecol; 2017 Mar; 216(3):285.e1-285.e6. PubMed ID: 27840142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.